Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AD-4833 add-on to SYR-322 in Type 2 Diabetes
NCT01686711Phase 4Completed
- Sponsor
- Takeda
- Start
- Sep 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Sep 2012; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01686711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01686711.